Home > Financial Ratios > NEULAND LABORATORIES

NEULAND LABORATORIES
Core EBITDA Growth

    Back to All Ratios
NEULAND LABORATORIES is part of below Screeners ↓
Top Small Cap Stocks with Best Fundamentals
Best Quarterly Growth Small Cap Stocks
COMMUNITY POLL
for NEULAND LABORATORIES
Please provide your vote to see the results

NEULAND LABORATORIES Last 5 Year Core EBITDA Growth History

[Consolidated]

Mar2025Mar2024Mar2023Mar2022Mar2021
   Core EBITDA Growth(%) -27.6568.7394.61-11.1854.02

What is the latest Core EBITDA Growth ratio of NEULAND LABORATORIES ?

The latest Core EBITDA Growth ratio of NEULAND LABORATORIES is -27.65 based on Mar2025 Consolidated results.
Year Core EBITDA Growth
Mar2025-27.65
Mar202468.73
Mar202394.61
Mar2022-11.18
Mar202154.02

How is Core EBITDA Growth of NEULAND LABORATORIES Trending?

Years Core EBITDA Growth % Change
Mar2025 -27.65
Negative
Mar2024 68.73
-27.35
Mar2023 94.61
Positive
Mar2022 -11.18
Negative
Mar2021 54.02 -

Other Financial Ratios of NEULAND LABORATORIES


Compare Core EBITDA Growth ratio of peers of NEULAND LABORATORIES

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
NEULAND LABORATORIES ₹19,443.5 Cr 0.6% -8.3% 9.1% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹412,626.0 Cr -1% -4.9% -7.6% Stock Analytics
DIVIS LABORATORIES ₹169,758.0 Cr -1.6% -0.4% 9.4% Stock Analytics
TORRENT PHARMACEUTICALS ₹130,021.0 Cr 0.2% 2.8% 12.2% Stock Analytics
CIPLA ₹122,046.0 Cr 1% -0.9% -1% Stock Analytics
DR REDDYS LABORATORIES ₹106,086.0 Cr 0.4% 0.9% -8.9% Stock Analytics


NEULAND LABORATORIES Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
NEULAND LABORATORIES

0.6%

-8.3%

9.1%

SENSEX

-0.4%

-0.6%

8.6%


You may also like the below Video Courses